Сибирский онкологический журнал (Feb 2016)

TUMOR MARKERS СА 125 AND НЕ 4 AS PROGNOSTIC AND PREDICTIVE FACTORS IN BORDERLINE OVARIAN TUMORS

  • A. N. Vasilyev,
  • S. E. Krasilnikov,
  • V. Е. Voitsitsky,
  • A. V. Gerasimov,
  • A. P. Kulidzhanyan,
  • Е. V. Babayants,
  • V. G. Sisakyan,
  • М. I. Krylyshkin,
  • N. A. Afanasyeva,
  • A. S. Mansurova

Journal volume & issue
Vol. 1, no. 4
pp. 39 – 44

Abstract

Read online

The aim of the study was to evaluate the relationship between serum levels of tumor markers СА 125 and НЕ 4 and disease stage, histological type as well as treatment in patients with borderline ovarian tumors. Materials and methods. Thirty patients with borderline ovarian tumors were retrospectively studied. The control group consisted of 70 patients with ovarian cancer and 30 healthy women. Results. Expression levels of СА 125 and НЕ were higher in patients with borderline tumors than in healthy women. In patients with stage I-II borderline ovarian tumors, СА 125 and НЕ 4 levels were similar to those observed in patients with ovarian cancer. However, in patients with stage III borderline ovarian tumors. After completing treatment, a significant reduction in the expression of СА 125 and НЕ 4 markers occurred. Conclusion. Tumor markers HE4 and CA125 can be predictive factors for tumor response to therapy and the tool for detecting patients at high risk for ovarian cancer.

Keywords